BCAB - BioAtla, Inc.
4.59
-0.320 -6.972%
Share volume: 27,975
Last Updated: 04-17-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$4.91
-0.32
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-07-2024 | 03-27-2025 | 05-06-2025 | 11-13-2025 | |
| Cash flow financing | -13.000 K | 225.000 K | -14.000 K | 9.313 M | -395.000 K | -6.000 K | |
| Other financing cash flows | -13.000 K | -19.000 K | -14.000 K | 0.000 | -29.000 K | -6.000 K | |
| Cash flow | -30.841 M | 0.000 | 0.000 | 0.000 | -16.683 M | 0.000 | |
| Net income | -23.234 M | -21.072 M | -10.586 M | -14.884 M | -15.334 M | -15.778 M | |
| Depreciation | 240.000 K | 229.000 K | 228.000 K | 228.000 K | 183.000 K | 56.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -30.841 M | -18.968 M | -5.146 M | -7.470 M | -16.683 M | -9.887 M |